SCHEMBL2680934

SCHEMBL2680934

C(=N/[C@H]1CCCC[C@@H]1/N=C/c1ccccc1)\c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
LMNA P02545 1/20 0.46
ACHE P22303 7/20 0.45
BACE1 P56817 7/20 0.45
KMT2A Q03164 1/20 0.44
BCHE P06276 3/20 0.42
THRB P10828 2/20 0.42
GAA P10253 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
NOX1 Q9Y5S8 1/20 0.38
GRIN1 Q05586 2/20 0.36
GRIN2B Q13224 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754804 1.00 L3MBTL1 (0.56) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL13957726 1.00 L3MBTL1 (0.56) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL4893960 1.00 L3MBTL1 (0.56) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL1705363 0.87 L3MBTL1 (0.49) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL12995094 0.87 L3MBTL1 (0.49) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL1705362 0.87 L3MBTL1 (0.49) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL1755570 0.87 L3MBTL1 (0.45) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL1755571 0.87 L3MBTL1 (0.49) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL6397984 0.87 L3MBTL1 (0.49) L3MBTL1LMNAACHEBACE1KMT2A
SCHEMBL8415735 0.83 KMT2A (0.63) L3MBTL1LMNAACHEBACE1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088346-B2 Alkene hydrofunctionalization reactions UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2012-01-03 US disclosed
US-8088346-B2 Alkene hydrofunctionalization reactions UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2012-01-03 US disclosed
US-20090069580-A1 Alkene Hydrofunctionalization Reactions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-03-12 US disclosed
US-20090069580-A1 Alkene Hydrofunctionalization Reactions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069580-A1 Alkene Hydrofunctionalization Reactions ADH1A, ADH1C, ADH5 L3MBTL1 3416/4885LMNA 4446/4885ACHE 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.